Transform your drug development pipeline with Newcells’ Renal Proximal Tubule Cells Model eBook. This eBook provides insight into the science behind aProximate™, an innovative proximal tubule cell model designed to mimic human kidney function with exceptional accuracy. It will also look at how it is being used in areas like preclinical research, helping to advance our understanding of nephrotoxicity, drug interactions, and renal disease mechanisms.
Discover how aProximate™ is helping researchers with a dependable, human-relevant platform for predictive kidney studies and high-throughput drug screening. Whether you are exploring renal pathophysiology or fine-tuning therapeutic strategies, this guide offers practical knowledge and proven protocols to take your research to the next level.
Download the eBook today and discover how aProximate™ is transforming kidney model systems in drug discovery and beyond.
Download the full eBook
About Newcells Biotech
Newcells Biotech develops in vitro cell-based assays for drug and chemical discovery and development.
Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology, and organoid technology, we build models that incorporate the “best biology” for predicting in vivo behavior of new drugs.
Our experts have developed and launched assays to measure transporter function, safety, and efficacy in a range of cell and tissue types, including kidney, retina and lungs.
We have the capability to develop and implement protocols to measure cilia beat frequency and toxicity on small airway epithelial cells model, retinal toxicity and disease modelling on retinal organoids and retina epithelium, as well as drug transport in the kidney, DDI and nephrotoxicity across human and a range of preclinical species.
Our development teams are creating models of the lung and liver to expand our offer to support early drug discovery and development.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.